Effects of Metformin-Single Therapy on the Level of Inflammatory Markersin Serum of Non-Obese T2DM Patients with NAFLD - Concepedia

Concepedia

Publication | Closed Access

Effects of Metformin-Single Therapy on the Level of Inflammatory Markersin Serum of Non-Obese T2DM Patients with NAFLD

14

Citations

0

References

2021

Year

Bojan Mitrovic, Zoran Gluvić, Milan Obradović, Emina Sudar-Milovanović, Sanja Šoškić, Dragan Stajić, Esma R. Isenović

Endocrine Metabolic & Immune Disorders - Drug Targets

Abstract

This pilot study suggests that the serum inflammatory markers at the average normal values point to the sufficiency of metformin-single therapy in inflammation control in non-obese T2DM patients with NAFLD.